These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21089597)

  • 1. [NMR in the fragment-based drug discovery].
    Hanzawa H; Takizawa T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
    [No Abstract]   [Full Text] [Related]  

  • 2. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practice of fragment-based lead discovery by X-rays].
    Yamano A
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR in drug discovery on membrane proteins.
    Wirmer-Bartoschek J; Bartoschek S
    Future Med Chem; 2012 May; 4(7):869-75. PubMed ID: 22571612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fragment-based lead discovery from smaller fragments to functional ligand].
    Hatayama A; Habashita H
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent advances in structure-based drug discovery].
    Honma T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1582-9. PubMed ID: 21089592
    [No Abstract]   [Full Text] [Related]  

  • 8. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract]   [Full Text] [Related]  

  • 9. Label-free technologies and pharmacology.
    Fang Y
    Pharmacol Res; 2016 Jun; 108():88-89. PubMed ID: 27155057
    [No Abstract]   [Full Text] [Related]  

  • 10. Design and NMR-based screening of LEF, a library of chemical fragments with different local environment of fluorine.
    Vulpetti A; Hommel U; Landrum G; Lewis R; Dalvit C
    J Am Chem Soc; 2009 Sep; 131(36):12949-59. PubMed ID: 19702332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences in fragment-based lead discovery.
    Hubbard RE; Murray JB
    Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment screening to predict druggability (ligandability) and lead discovery success.
    Edfeldt FN; Folmer RH; Breeze AL
    Drug Discov Today; 2011 Apr; 16(7-8):284-7. PubMed ID: 21315179
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear magnetic resonance in target profiling and compound file enhancement.
    Sun C; Hajduk PJ
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):463-70. PubMed ID: 16889229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR screening in fragment-based drug design: a practical guide.
    Kim HY; Wyss DF
    Methods Mol Biol; 2015; 1263():197-208. PubMed ID: 25618347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR spectroscopy: the swiss army knife of drug discovery.
    Horst R; Farley KA; Kormos BL; Withka JM
    J Biomol NMR; 2020 Nov; 74(10-11):509-519. PubMed ID: 32617727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in nuclear magnetic resonance for drug discovery.
    Sillerud LO; Larson RS
    Methods Mol Biol; 2012; 910():195-266. PubMed ID: 22821598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of molecular diversity in drug discovery.
    Marcaurelle LA; Foley MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):285-8. PubMed ID: 20472491
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
    Evensen L; Micklem DR; Link W; Lorens JB
    Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in fragment-based lead discovery.
    Schulz MN; Hubbard RE
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.